Li, Yixuan
Wu, Yi
Cai, Shufan
Huang, Xiangxin
Ye, Lijun
Wang, Lin
Zhang, Yingying
Wang, Ying https://orcid.org/0000-0003-2121-7025
Tao, Xuexia
Funding for this research was provided by:
Major Projects of Hangzhou Health Science and Technology (No. Z20220024)
The Zhejiang Province Leading Geese Plan (2024C03099)
Key R&D Program of Hangzhou Science and Technology Bureau (20241203A17)
Article History
Received: 8 July 2025
Accepted: 28 September 2025
First Online: 31 October 2025
Declarations
:
: Yixuan Li, Yi Wu, Shufan Cai, Xiangxin Huang, Lijun Ye, Lin Wang, Yingying Zhang, Ying Wang, and Xuexia Tao declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The study was approved by the Ethics Committee for Clinical Trials of Hangzhou First People’s Hospital (Approval Number: HS-BDKL-BE-05).
: All study participants provided written informed consent.
: All researchers, participants, institutions, and sponsors consented to the submission of this report to the journal.
: The datasets generated and/or analyzed during the current study are not publicly available. However, the data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not applicable.
: YL, YW, and SC conceptualized and designed the study. XH and LY collected clinical trial data. LW and YZ performed data management. YL drafted the manuscript. XT and YW critically revised the manuscript and supervised the overall project. All authors reviewed the manuscript. All authors read and approved the final version of the manuscript.